Blood test predicts success of neuroendocrine cancer therapy
Malignant neuroendocrine tumors (NETs) are relatively rare, notoriously difficult to treat, and associated with poor long-term survival. According to research presented at the 2016 Annual Meeting of the Society of Nuclear ...
Jun 13, 2016
0
2